Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CALM-ICH: Angong Niuhuang for Acute Intracerebral Hemorrhage
NCT07752719Phase 3Not yet recruiting
- Sponsor
- Fudan University
- Start
- Oct 2026
- Primary completion
- Jan 2029
01
Overview
Phase 3, randomised, double-blind trial in intracerebral hemorrhage (ICH) comparing Early Angong Niuhuang Pill (ANP) treatment with Placebo (2 arms). Primary endpoint: modified Rankin scale scores at 180 days. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
Angong Niuhuang Pill
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT07752719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07752719.